Camgenium’s medical device supports pregnant women at risk of pre-eclampsia

Camgenium, a leading medical device software company, has announced that its software product, ‘Reassure Pregnancy’, can improve outcomes for pregnant women at risk of pre-eclampsia through at-home monitoring.

Reassure Pregnancy is currently in use at Milton Keynes University Hospital NHS Foundation Trust and University Hospitals Dorset in Poole. It was first introduced to Milton Keynes University Hospital in November 2018 and later to University Hospitals Dorset in April 2019. Reassure Pregnancy was provided free of charge to both hospitals throughout the COVID-19 pandemic to ensure that individuals in high-risk pregnancies didn’t need to make any unnecessary trips to the hospital, which could have exposed them to the virus.

Pre-eclampsia is a medical condition characterised by high blood pressure and the presence of protein in urine.The preliminary symptoms of pre-eclampsia are often undetected by pregnant women but early diagnosis and management are essential for preventing maternal and neonatal complications. Typically, the condition is diagnosed and monitored during routine prenatal appointments at the maternity clinic by measuring blood pressure and urine protein levels.i Women found to be at high risk require more frequent testing which can be burdensome for the mother and is expensive for the clinic. The Reassure Pregnancy app enables frequent testing, saving time and cost for the clinic and, more importantly, ensuring that clinicians can take action at the first sign of a problem.

Sign up for Blog Updates